奎尔丁对心肌梗塞患者的影响. 一个多中心,随机和开放标签试点研究
Sergey Kozhukhov1, Alexander Parkhomenko2, Yaroslav Lutay2
1Clinical Pharmacology Department, NSC "The M.D.Strazhesko Institute of Cardiology", Kyiv, Ukraine.
概括
奎尔素补充剂可能会限制心脏病发作的大小,并减少ST段升高心肌梗塞 (STEMI) 患者的心脏内出血. 这项试点研究表明,氨酸可以作为STEMI的潜在辅助疗法,在再注射后改善结果.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 心肌梗塞 (MI) 仍然是全球主要的死亡原因.
- 早期再输血对于改善急性心脏病发作的存活率至关重要.
- 生物类黄胺表现出抗氧化,抗炎和抗增殖的特性.
研究的目的:
- 研究奎尔丁在限制ST段升高心肌梗塞 (STEMI) 患者心脏病发作大小方面的心脏保护作用.
- 评估奎尔丁对STEMI患者缺血/再输损伤的影响.
主要方法:
- 一项试点,开放标签,多中心研究包括143名在6小时内出现症状的前部STEMI患者.
- 患者被随机分配,接受标准治疗加上夸塞丁输注或单独接受标准治疗 (对照).
- 通过曲线下的肌酸激酶-心肌带面积 (CK-MB AUC) 评估的心脏梗塞大小是主要结果.
主要成果:
- 与对照组相比,奎尔丁组的早期CK-MB AUC中位数显著降低 (p=0.015).
- 静脉注射奎尔丁与第3天心内出血减少有关 (11.1%与53.3%,p<0.024).
- 在左心室喷射率或重塑指标上没有观察到显著差异.
结论:
- 这项试点研究为STEMI中缺血/反损伤提供了新的见解.
- 在标准的STEMI治疗中添加奎尔丁似乎可以限制心脏病发作的大小,并预防心脏内出血.
- 需要进一步的研究来验证和扩展这些有希望的发现.
更多相关视频
09:53Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
Published on: January 10, 2025
468
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
3.5K
相关概念视频
01:14Myocarditis III: Medical Management
9
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
01:28Acute Coronary Syndrome IV: Interprofessional Care
12
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12
01:26Angina IV: Management
11
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
11
01:22Myocarditis IV: Nursing Management
13
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
13
01:17Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
01:26Coronary Artery Disease IV: Preventive Measures
24
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
24